FindTrial
Sign In

Ultrasound radiomics on differentiation of kidney cancer

Ultrasound radiomics on differentiation of kidney cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040514
Enrollment
Unknown
Registered
2020-12-01
Start date
2020-11-30
Completion date
Unknown
Last updated
2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Tumor

Interventions

Gold Standard:Pathological results
Index test:Radiomics, nomogram

Sponsors

Depariment of Ultrasound, Tongji Hospital, Tongji Medical University, Huazhong University of Science and Technology, Wuhan, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with kidney tumor; 2. Have performed operation; 3. Have determined pathology results; 4. With full clinical information.

Exclusion criteria

Exclusion criteria: 1. Patients only with cystic tumors; 2. Have experienced other treatment before ultrasound; 3. Have other related disease.

Design outcomes

Primary

MeasureTime frame
Radiomics features;—

Countries

China

Contacts

Public ContactXin-Wu Cui

Tongji Hospital Affiliated to Tongji University

cuixinwu@live.cn+86 15927103161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026